Expired activity
Please go to the PowerPak
homepage and select a course.
Aging Well with HIV: Strategies to Mitigate Cardiovascular Risk in Older Adults
Provided by Boston University School of Medicine and The University of Rhode Island College of Pharmacy.
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Program Description
This two-module activity addresses the current state of HIV in the US and healthy aging considerations for persons living with HIV (PLWH). Also included are brief vignettes of actual patient interviews. Their perspectives will provide insight into the daily challenges and quality of life issues that can occur while living with HIV.
Our experts discuss the changes in care due to the advent of highly active antiretroviral therapy (HAART). Life expectancies for PLWH are now similar to those for uninfected people. A growing proportion of HIV-infected individuals are now over the age of 50, and we are also seeing an increase in the incidence of HIV infection in older adults. To meet the challenges of the ongoing HIV epidemic, HIV care providers must now address the many comorbidities that are common in the aging population.
Cardiovascular diseases (CVD) are among the most prevalent non-communicable comorbidities in PLWH, and gaps in optimal CV risk factor management in this population is illustrative of the need to emphasize an aging-centric approach to the care of older PLWH. From a cardiovascular standpoint, routine risk screening for cardiovascular health maintenance metrics is sub-optimal, which can result in under-identification and/or under-treatment. Additionally, older adults living with HIV infection may be doubly stigmatized, as they are branded by both age as well as HIV status.3 And with any chronic disease, adherence remains a significant problem in HIV as well.
The growing number of PLWH over age 50 requires research, to develop a more comprehensive understanding of the health consequences of HIV in older individuals. The intent of this CME program is to help clinicians improve the health of older PLWH.
Intended Audience
Infectious disease specialists, geriatricians, primary care and internal medicine physicians, pharmacists, NP/PAs, and nurses
Educational Objectives
After completing this activity, participants should be able to:
- Evaluate age-related considerations for treating HIV to promote better health in the aging population.
- Review the relationship between HIV and cardiovascular disease along with how to manage them together in practice.
- Identify factors that hinder medication adherence in PLWH and ways to overcome these barriers.
- Utilizing video vignettes of actual patients, identify opportunities for improving health-related quality of life among older patients living with HIV from a multidimensional care lens.
- Recognize forward-thinking strategies clinicians can employ to optimize treatment and positive health outcomes for their patients with HIV while mitigating the risk of infection from COVID-19.
PUBLISHED
August 1, 2021
EXPIRES
August 1, 2022
Accreditation Statements
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This is an application-based educational activity. Pharmacists will receive 2.5 contact hours (0.25 CEUs) for the educational activity. No partial credit is available. Initial Release Date: August 1, 2021. Planned Expiration Date: August 1, 2022.
Universal Activity Number (UAN): 0060-9999-21-021-H01-P
Estimated Time to Complete: 2 hours and 30 minutes
Accreditor Disclosure of Conflicts of Interest Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Faculty Info
Archana Asundi, MD
Course Director
Assistant Professor
Boston University School of Medicine
Department of Medicine, Infectious Diseases
Boston Medical Center
Boston, MA
Stephen Brady, PhD
Director
Mental Health Counseling and Behavioral Medicine Program
Associate Professor of Psychiatry
Boston University School of Medicine
Boston, MA
Peter W. Hunt, MD
Professor of Medicine in Residence
Division of Experimental Medicine
Co-Director, UCSF-Bay Area Center for AIDS Research
University of California, San Francisco
San Francisco, CA
Annie Potter, MSN, MPH, NP, CARN-AP
NCPD Course Advisor
Assistant Professor
Boston University School of Medicine
Department of Medicine, General Internal Medicine
Boston Medical Center
Boston, MA
Alejandra Salazar, RPh, PharmD, AAHIVP
Clinical Specialist
Boston Medical Center
Center for Infectious Diseases
Boston, MA
Irina Vovnoboy, MD
Co-Course Director
Assistant Professor
Boston University School of Medicine
Department of Medicine, Geriatrics
Boston Medical Center
Boston, MA
Faculty Disclosures
Dr.
Asundi receives research grant support from GlaxoSmithKline/ViiV,
Roche/Genentech, Gilead Sciences, DayZeroDiagnostics, and Merck.
Dr. Hunt receives research support from Gilead Sciences. He is a consultant for ViiV and Biotron, and he is on the advisory board for Biotron.
Dr. Brady, Ms. Potter, Dr. Salazar, and Dr. Vovnoboy have no relevant financial relationships to disclose.
Accreditor Disclosures
The following members of Boston University School of Medicine’s Continuing Medical Education Office, have no relevant financial relationships to disclose:
Natalie Sanfratello, MPH, Program Manager
Michael Burk, Senior Program Manager
Dana Frazier-Price MS, CHCP, Grant Development Manager
Jessica Martin, PhD, Consultant Medical Editor
Carmela A. Townsend, DNP, MS/MBA, RN, Lead Nurse Planner
Mary-Jane Kanaczet, M. Ed., Director, Office of Continuing Professional Development,
College of Pharmacy, University of Rhode Island, has no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
Faculty members do not plan to discuss unlabeled/investigational uses of a commercial product.
Disclaimer
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
How to Earn Credit
Participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
For information about the accreditation of this program, please contact cme@bu.edu
To view Boston University’s Privacy Policy, please see https://cme.bu.edu/content/privacy-statement
© Trustees of Boston University, 2021
